Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
01 1Malladi Drugs & Pharmaceuticals Limited
02 1AbbVie Inc
03 1Suanfarma
04 1TAPI Technology & API Services
05 1Abbott Laboratories
06 1Curia
07 1Fuan Pharmaceutical
08 1Grand Health Industrial Co Ltd
09 1Hikal
10 1Merck & Co
11 1Sri Krishna Pharmaceuticals
12 1TBD Pharmatech
13 1Tasmanian Alkaloids Pty Ltd
14 1Teva Pharmaceutical Industries
15 1Unipex
01 1Australia
02 2China
03 1Estonia
04 1France
05 3India
06 2Israel
07 1Spain
08 4U.S.A
01 5Active
02 3Inactive
03 7Blank
01 15Blank
01 15Blank
01 1WC-0094nA2A
02 14Blank
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8904
Submission : 1990-12-20
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-29
Pay. Date : 2012-11-13
DMF Number : 10385
Submission : 1993-08-02
Status : Active
Type : II
Available Reg Filing : CA, ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25670
Submission : 2012-01-17
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-26
Pay. Date : 2022-04-18
DMF Number : 31875
Submission : 2017-06-29
Status : Active
Type : II
Date of Issue : 2022-06-14
Valid Till : 2025-09-02
Written Confirmation Number : WC-0094nA2A
Address of the Firm :
NDC Package Code : 66651-920
Start Marketing Date : 2017-07-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14842
Submission : 2000-04-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12119
Submission : 1996-09-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12921
Submission : 1998-03-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9127
Submission : 1991-05-20
Status : Inactive
Type : II
NDC Package Code : 47848-005
Start Marketing Date : 2013-02-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Butorphanol Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butorphanol Tartrate, including repackagers and relabelers. The FDA regulates Butorphanol Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butorphanol Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Butorphanol Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Butorphanol Tartrate supplier is an individual or a company that provides Butorphanol Tartrate active pharmaceutical ingredient (API) or Butorphanol Tartrate finished formulations upon request. The Butorphanol Tartrate suppliers may include Butorphanol Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Butorphanol Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 15 companies offering Butorphanol Tartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?